Rafael Tirado-Montijo, MD
Gastroenterology · Manati, PRNPI 1285947127
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,600 of the $7,432 with a category attached, or 61.9%. AbbVie accounts for 84.3% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $5,154, more than ten times the $233 reported in 2019.
Across 95 payments — averaging $78.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- E.r. Squibb & Sons, L.L.C.$569
- Gilead$276
- Takeda Pharmaceuticals U.S.A., Inc.$134
- Eli Lilly Export S.A. Puerto Rico Branch$70
- Edwards Lifesciences$46
- plus $69 from 3 others
What the payments were for
- Consulting fees$4,60062%
- Travel & lodging$280%
- Food & beverage$2,80438%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $6,267 |
| E.r. Squibb & Sons, L.L.C. | 22 | $569 |
| Gilead | 13 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $134 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $70 |
| Edwards Lifesciences | 1 | $46 |
| Johnson & Johnson | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Olympus Latin America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,432 in reported general payments places this provider in the 80th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 212 | $25,512 |
| SuprepSodium, Potassium,mag Sulfates | 138 | $16,296 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 89 | $14,862 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 72 | $6,030 |
| Dexlansoprazole DrDexlansoprazole | 20 | $4,477 |
| Pantoprazole Sodium | 270 | $1,909 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 78 | $1,891 |
| CholestyramineCholestyramine (With Sugar) | 31 | $1,864 |
| Clarithromycin | 53 | $1,429 |
| Famotidine | 185 | $1,068 |
| Ursodiol | 16 | $777 |
| Omeprazole | 124 | $662 |
| Amoxicillin | 45 | $607 |
| Midazolam HclMidazolam Hcl/Pf | 201 | $563 |
| Fentanyl CitrateFentanyl Citrate/Pf | 167 | $556 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Manati
- Roberto Rodriguez RamosManati$10K
- Fray Arroyo MercadoManati$8K
- Juan Marques LespierManati$4K
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Rafael Pastrana LabordeHato Rey$76K
- Miguel de Varona-NegronCaguas$68K
- Marcia Cruz CorreaSan Juan$62K
- Francisco CebolleroMayaguez$52K
- Loscar SantiagoSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.